IAPAM Medical Aesthetics, Botox, Medical Weight Loss Information - Page 3

Celebrating 20 Years of Training in Botox®, Aesthetic Medicine
and Medical Weight Management

Aesthetic Medicine Symposium - September 18-21 in Scottsdale, AZ! Secure Your Spot

Celebrating 20 Years of Excellence in Botox®, Aesthetic Medicine & Medical Weight Management Training & Certification

Aesthetic Medicine Symposium — Sept 18–21, Scottsdale, AZ Secure Your Spot →

How to Start Aesthetic Medicine in 2026: A Provider Roadmap

If you’ve been considering aesthetic medicine, 2026 may be the best entry window in years — a documented provider shortage, a wave of new patients, and a training path that’s more accessible than most providers realize. Here’s the realistic roadmap.

Regenerative Aesthetics 2026: What the Evidence Actually Supports

Not all regenerative aesthetics treatments are created equal — and in 2026, the evidence gap between them is wider than most product reps will tell you. Here’s an honest evidence rating for every major regenerative modality, plus a practical framework for talking to patients about what you can and can’t confidently offer.

Woman relaxing during NAD+ IV therapy with an IV drip and scientific molecular graphics overlay in the background.

IV NAD+ Therapy in 2026: What Aesthetic Providers Need to Know

Patients are arriving at aesthetic and weight management practices asking about NAD+. Here’s the clinical case for IV delivery, what the evidence actually shows, and how to build it into a practice already serving this patient.

GLP-1 Aesthetic Patients: A Clinical and Business Framework

63% of patients on GLP-1 medications are new to aesthetics — and they’re arriving with a distinct presentation that requires a different clinical and business approach. Here’s what GLP-1 aesthetic patients actually need from their provider, and how to build a practice model that serves them well.

Doctor with stethoscope beside a monitor and a green promotional banner that reads 'The Latest GLP-1 Trends' (April 2026 Edition).

GLP-1 Clinical Practice Updates: April 2026 Key Developments

April 2026 brought a wave of regulatory and clinical developments that GLP-1 providers need to act on before summer. From a landmark FDA compounding proposal to the Medicare GLP-1 Bridge program’s July 1 launch, here is what changed and what it means for your practice.